Quick Answer
LENZ Therapeutics, Inc. reported Total Assets of $305.88 million for fiscal year 2025.
LENZ Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $305.88M | +42.1% |
| 2024 | $215.30M | +205.9% |
| 2023 | $70.38M | -78.1% |
| 2022 | $321.90M | -19.9% |
| 2021 | $401.99M | +1681.5% |
| 2020 | $22.56M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $210.70M | -5.9% | -3.0% |
| June 30, 2025 | $217.33M | +7.3% | +8.0% |
| March 31, 2025 | $201.25M | -7.4% | -6.5% |
| December 31, 2024 | $215.30M | +205.9% | -3.9% |
| September 30, 2024 | $224.01M | -15.9% | +10.5% |
| June 30, 2024 | $202.64M | -29.4% | -6.8% |
| March 31, 2024 | $217.32M | -29.9% | +208.8% |
| December 31, 2023 | $70.38M | -78.1% | -73.6% |
- LENZ Therapeutics, Inc. showed an increase of +42.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, LENZ Therapeutics, Inc.’s total assets has grown by 1255.6% (from $22.56 million to $305.88 million).
- The most recent figure is from LENZ Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: